ArticleAdvanced materials (Deerfield Beach, Fla.)2026
Geometry-Programmable Living Immunomaterials for Spatial Control of Innate Immune Signaling.
Article in Advanced materials (Deerfield Beach, Fla.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Spatial organization of immune ligands critically regulates cGAS-STING signaling by controling the nanoscale geometry that drives cooperative cGAS assembly and catalytic activity. Here we engineer geometry-programmable DNA origami that precisely encodes double-stranded DNA (dsDNA) valency and spacing to promote cooperative cGAS clustering and STING activation. Systematic architectural modulation identifies an optimal configuration within tested ranges, in which 60-bp dsDNA ligands arranged with ∼16.3 nm periodicity induce approximately twofold stronger STING signaling than free dsDNA counterparts. We further integrate these origamis with the probiotic Escherichia coli Nissle 1917 via transporter-mediated surface anchoring, forming a living immunomaterial interface for localized ligand presentation in colorectal tumors. In microsatellite-stable colorectal cancer models, this biohybrid system drives robust intratumoral STING activation, promotes T-cell-inflamed immune remodeling, and suppresses tumor growth by ∼83.5% relative to controls. This work establishes a geometry-programmable living immunomaterial translating nanoscale architectural design into spatially confined innate immune signaling.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.